Portal de Periódicos da CAPES

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

2005; Springer Nature; Volume: 93; Issue: 6 Linguagem: Inglês

10.1038/sj.bjc.6602774

1532-1827

J. Blake Bartlett, A.W. Tozer, David Stirling, Jerome B. Zeldis,

Cancer Treatment and Pharmacology

Thalidomide is effective in the treatment of multiple myeloma. The immunomodulatory drug and thalidomide analogue lenalidomide is currently in late stage clinical development for MDS and multiple myeloma. This minireview highlights the course of initial and ongoing lenalidomide clinical development in oncology with reference to earlier thalidomide studies.